ALLEVIATE TOGETHER.
RESEARCH PROJECTS.
KNOWLEDGE TRANSFER
THROUGHOUT EUROPE.
The European Tinnitus Network
Our vision
EUTINNET was founded in 2019 under the umbrella of the German Foundation Tinnitus & Hearing Charité. The network unites numerous European tinnitus self-help organisations and is in active exchange with leading ENT universities and research institutions in Europe.
The common goal is to promote transfer of knowledge on treatment options for tinnitus and other hearing impairments in the member countries, to organise research projects and to create even more awareness for the careful handling of hearing through communication and education.
Please find detailed information on our goals in our information flyer:
The Top 5 EUTINNET Goals (PDF, 226 KB)
Our team
Across Europe, millions of people suffer from chronic tinnitus or diseases of the inner ear, such as hearing loss, hyperacusis or Meniere’s disease. These can lead to a severe restriction of quality of life and performance in both the professional and private spheres.
The EUTINNET specialists bring their many years of expertise from the fields of ENT medicine, psychosomatics and psychology to promote the Europe-wide exchange between scientists and self-help-organisations and to realise joint research projects.
Dr. med. Eberhard Biesinger
Coordinator EUTINNET
ENT-Center Traunstein
Prof. Dr. Birgit Mazurek
Chairwoman of the Board, Tinnitus & Hearing Foundation Charité
Director Tinnituszentrum Charité – Universitätsmedizin Berlin, Germany
Prof. Dr. Christian Dobel
Chairman of the Scientific Board, Tinnitus & Hearing Foundation Charité
Professor for Experimental ENT Science, ENT Clinic, Friedrich Schiller University Jena, Germany
Members
EUTINNET members
The network currently has 10 member organisations from Europe. Together they help to promote the exchange of experience and to advance research projects. New members are welcome.
For more information, please click on the respective logo.
United Kingdom
The Netherlands
The Netherlands
Switzerland
Germany
Austria
Belgium
France
Italy
Denmark
Study
About the web-based database
This study aims to provide information about the relationship between tinnitus, hyperacusis and other comorbidities, such as stress, anxiety and depression. This is done by comparing the data of affected persons entered via the two tinnitus questionnaires and three further comorbidity questionnaires.
In the long term, a longitudinal data follow-up is planned to include further survey results in the database.
The six questionnaires
The socio-demographic questions ask for specific characteristics about the person, which are important in order to be able to carry out the scientific evaluation of the subsequent surveys on tinnitus, hyperacusis as well as stress, anxiety and depression in a more differentiated way and to derive the correct scientific results and findings per group.
The Mini-Tinnitus Questionnaire (Mini-TF12) provides information about the intensity with which the tinnitus influences your feelings and attitudes.
The aim of the Tinnitus Impairment Questionnaire (TBF12) is to give you, as a person affected, the opportunity to state concrete difficulties and impairments that you personally experience due to your ringing in the ears.
The Mini Hyperacusis Questionnaire (Mini-HQ9) asks about discomfort you experience from external noises of any kind. The aim is to find out if your noise hypersensitivity has any influence on your feelings, behaviour or attitude.
The Perceived Stress Questionnaire (PSQ9) is used to determine your subjective perception, evaluation and processing of stress factors, because the subjective feeling of stress is one of the decisive factors for the course of various diseases and disorders.
Finally, the Hospital Anxiety and Depression Scale (HADS) measures various forms of anxiety and depression in patients with physical illnesses or (possibly psychogenic) physical complaints.
Who is the study aimed at?
The survey is aimed at people in Europe who suffer from tinnitus and/or hyperacusis and who are willing to provide information about related concomitant diseases and impairments as part of a Europe-wide survey.
Why is your participation important?
The more people participate in the Europe-wide study, the more data can be collected and analysed by the EUTINNET Scientific Board. The results should provide new insights to improve diagnostic possibilities as well as therapeutic and medical treatment options.
If you have any questions about the Europe-wide data collection within the framework of the present study, please contact:
Dr. med. Eberhard Biesinger, Specialist in Otorhinolaryngology, Coordination EUTINNET
E-Mail: info@eutinnet.org
News
Berlin, 5 February 2026: TRI Conference in Berlin 16-18 September 2026
We proudly announce the 20th Tinnitus Research Initiative (TRI) Conference 2026.The Tinnitus Zentrum Charité – Universitätsmedizin Berlin and the German Foundation Tinnitus & Hearing Charité are jointly organizing this international conference, which will take place in Berlin from 16 – 18 September 2026. Hundreds of world-leading tinnitus experts will gather at Campus Charité Mitte in Berlin to share the latest in research, diagnosis and treatment of tinnitus. The interdisciplinary exchange of knowledge between ENT, neurology, audiology and psychology will help to better understand how tinnitus originates in order to alleviate the symptoms and, in the future find a cure for it. The scientific directors of the conference are Professor Birgit Mazurek and Professor Berthold Langguth.
All experts from Europe and around the world are cordially invited to register online for participation. The programme, all information on ticket prices, and the link to the registration plattform can be found here.
Berlin, 6 December 2025: Research Prize Tinnitus and Hearing
This year, the foundation once again received numerous applications from Germany and other European countries for the Research Prize Tinnitus and Hearing. The Scientific Advisory Board reviewed all submissions and ultimately selected Dr. rer. nat. Konstantin Tziridis as ths years winner. The postdoctoral researcher and scientific staff member for neurobiological basic research – Experimental ENT Medicine at the ENT Clinic of the Friedrich-Alexander University Erlangen-Nürnberg (FAU) – received the highest rating for his study“A Single Dose of AC102 Reverts Tinnitus in Noise-Exposed Mongolian Gerbils by Restoring Ribbon Synapses.”
AC102 is a promising, new compound from AudioCure Pharma GmbH that may protect hair cells from degeneration and promote the restoration of neural connections (synapses) from the inner ear to the brain. Following a successful Phase 1 study, AC102 is currently being tested in a European Phase 2 study in patients with sudden hearing loss, where it is injected directly into the middle ear and could potentially be more effective than, for example, cortisone.
The Advisory Board emphasized the outstanding scientific and clinical relevance of the study and expressed it’s hope that this award represents another step toward an effective medical treatment for tinnitus patients.
Welcome to EUTINNET, the European Tinnitus Network
As a member, you join a diverse group of tinnitus and hearing loss organizations from across Europe, all focused on improving awareness, sharing research, and supporting those affected by tinnitus and related conditions. By connecting with experts, researchers and patient communities, you contribute to advancing treatment options and fostering collaboration across borders. Your involvement helps to strengthen the network’s mission of promoting knowledge transfer and improving the quality of life for those impacted by tinnitus.
Unsere News auf Social Media:
Interessante Neuigkeiten aus dem EUTINNET-Netzwerk, Termine sowie weitere Highlights zu den Themen Tinnitus, Hören, Hörbeeinträchtigungen sowie Diagnose- und Behandlungsmethoden posten wir regemäßig auf den Social Media-Kanälen der Stiftung Tinnitus und Hören Charité:
